Last Updated 16 May 2022.
2 Vaccines Approved for Use in Hong Kong
-
Pfizer/BioNTech
Comirnaty- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 146 countries
78 trials in 26 countries
Approval Source: reuters.com
-
Sinovac
CoronaVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 56 countries
37 trials in 9 countries
Approval Source: reuters.com
5 Vaccines in Clinical Trials in Hong Kong
-
Pfizer/BioNTech
Comirnaty- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 146 countries
78 trials in 26 countries
-
Oxford/AstraZeneca
Vaxzevria- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 140 countries
63 trials in 30 countries
-
Sinovac
CoronaVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 56 countries
37 trials in 9 countries
-
The University of Hong Kong
SARS-CoV-2 DNA Vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
The University of Hong Kong
DelNS1-nCoV-RBD LAIV- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country